Valuation : Celltrion Pharm, Inc.

Market Cap 4,67400Cr 62,94,18800Cr 4,02200Cr 3,78400Cr 3,45700Cr 6,46600Cr 4,41,26900Cr 6,48400Cr 44,71300Cr 17,35100Cr 2,26,40200Cr 17,55000Cr 17,16700Cr 7,29,36100Cr P/E 2019
166x
P/E 2020 417x
Enterprise Value 4,83700Cr 65,14,07400Cr 4,16200Cr 3,91600Cr 3,57700Cr 6,69200Cr 4,56,68500Cr 6,71000Cr 46,27500Cr 17,95700Cr 2,34,31100Cr 18,16300Cr 17,76700Cr 7,54,84100Cr EV / Sales 2019
9.06x
EV / Sales 2020 38x
Free-Float
44.28%
Yield 2019 *
-
Yield 2020 -
1 week-4.11%
Current month-2.04%
1 month-2.04%
3 months-10.81%
6 months-29.20%
Current year-29.57%
1 week 40,650
Extreme 40650
42,200
1 month 40,000
Extreme 40000
47,000
Current year 37,000
Extreme 37000
78,300
1 year 37,000
Extreme 37000
78,300
3 years 37,000
Extreme 37000
1,24,463.12
5 years 37,000
Extreme 37000
1,38,792.87
10 years 13,660.97
Extreme 13660.974887
2,21,035.48
Manager TitleAgeSince
Chief Executive Officer 61 26/03/2024
Director of Finance/CFO 53 -
Sales & Marketing 52 -
Director TitleAgeSince
Chairman 68 28/03/2025
Director/Board Member 77 28/03/2023
Director/Board Member 65 26/03/2021
Date Insider Type Main position Quantity % Market Cap. Importance
07/05/25 Others 24 0.0001%
07/05/25 Others 127 0.0003%
07/05/25 Exercice 4,500 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.11%-20.48%-32.74% 134.11Cr
-0.89%-1.09%+20.02%+71.25% 4.83TCr
-1.72%-1.15%+47.28%+115.51% 4.05TCr
-2.01%-5.96%+10.68%+80.50% 1.18TCr
-0.70%-2.70%-12.22%+11.80% 1.19TCr
+0.57%-0.56%+26.56%+154.33% 935.93Cr
-1.67%-0.35%+41.04%-12.04% 737.27Cr
+0.08%-4.11%+22.91%+43.56% 749.58Cr
-0.89%-3.09%+22.42%+220.05% 728.46Cr
-0.16%-2.36%-42.27%+15.39% 518.68Cr
Average -0.74%-2.11%+11.59%+66.76% 1.5TCr
Weighted average by Cap. -1.05%-1.72%+23.27%+83.27%

Financials

2019 2020
Net sales 17TCr 2,33,67500Cr 15TCr 14TCr 13TCr 24TCr 16,38200Cr 24TCr 1,66000Cr 64TCr 8,40500Cr 65TCr 64TCr 27,07800Cr 23TCr 3,14,55400Cr 20TCr 19TCr 17TCr 32TCr 22,05300Cr 32TCr 2,23500Cr 87TCr 11,31400Cr 88TCr 86TCr 36,45000Cr
Net income 860.22Cr 11,58500Cr 740.22Cr 696.44Cr 636.2Cr 1.19TCr 81TCr 1.19TCr 8.23TCr 3.19TCr 42TCr 3.23TCr 3.16TCr 1,34200Cr 2.09TCr 28,20000Cr 1.8TCr 1.7TCr 1.55TCr 2.9TCr 1,97700Cr 2.9TCr 20TCr 7.77TCr 1,01400Cr 7.86TCr 7.69TCr 3,26800Cr
Net Debt 15TCr 2,00,06100Cr 13TCr 12TCr 11TCr 21TCr 14,02600Cr 21TCr 1,42100Cr 55TCr 7,19600Cr 56TCr 55TCr 23,18300Cr 16TCr 2,19,88600Cr 14TCr 13TCr 12TCr 23TCr 15,41600Cr 23TCr 1,56200Cr 61TCr 7,90900Cr 61TCr 60TCr 25,48000Cr
Logo Celltrion Pharm, Inc.
Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.
Employees
328
Date Price Change Volume
04/26/04 ₩40,850.00 0.00% 47,726
03/26/03 ₩40,850.00 -0.73% 53,601
02/26/02 ₩41,150.00 -0.96% 77,116
01/26/01 ₩41,550.00 -0.36% 61,490
31/26/31 ₩41,700.00 -2.11% 98,719
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A068760 Stock